Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00147056 · ClinicalTrials.gov registry record · NA
MRI-Guided Focused Ultrasound Feasibility Study for Brain Tumors
A NA study of Brain Tumor, sponsored by InSightec.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT00147056: Active NA study of Brain Tumor, sponsored by InSightec.
NCT00147056 is a NA study of Brain Tumor that is active but no longer recruiting, run by InSightec. The registered enrollment target is 10 participants, below the 281-participant average among 69 other Brain Tumor trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00147056, a NA study of Brain Tumor, is active but no longer recruiting, sponsored by InSightec.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate the safety of MRI-guided focused ultrasound thermal ablation of brain tumors performed through intact human skull using the ExAblate transcranial system. We will collect data to establish the basic safety of this type of treatment as the basis for later studies that will evaluate its clinical efficacy.
Primary Outcome
To evaluate the safety of ExAblate TcMRgFUS treatment delivered through intact human skull to the brain, during the treatment and during the follow-up period of 3 months.
Conditions Studied
Interventions
- DEVICE ExAblate transcranial system
Study Locations (2)
Massachusetts
- Brigham and Women's Hospital - Boston
Washington
- Swedish Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-08 |
| Est. Completion | 2026-12 |
| Phase | NA |
What the registry record for NCT00147056 still lists
NCT00147056 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 281-participant average among 69 other Brain Tumor trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which ExAblate transcranial system is the first listed.
NCT00147056 reports a single indexed study location in Massachusetts, Washington.
Frequently Asked Questions
What is clinical trial NCT00147056 about?
NCT00147056 is a clinical study titled "MRI-Guided Focused Ultrasound Feasibility Study for Brain Tumors". The purpose of this study is to evaluate the safety of MRI-guided focused ultrasound thermal ablation of brain tumors performed through intact human skull using the ExAblate transcranial system. We will collect data to establish the basic safety of this type of treatment as the basis for later studi...
What is the current status of trial NCT00147056?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2012-08. Estimated completion is 2026-12.
What conditions does trial NCT00147056 study?
This clinical trial studies the following conditions: Brain Tumor.
What interventions are being tested in trial NCT00147056?
The interventions under investigation include: ExAblate transcranial system (DEVICE).
Who is sponsoring clinical trial NCT00147056?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00147056 being conducted?
This trial has 2 study locations across Massachusetts, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00147056's enrollment target sits among peer trials
10 64th of 69 higher than 4 of 69 other Brain Tumor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Tumor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
RECRUITING · NA
-
Cognitive Training in the Virtual Reality Setting With Children Undergoing Radiotherapy for Brain Tumors
RECRUITING · NA
-
Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption
RECRUITING · NA
-
Ommaya Reservoir Placement for Brain Tumor Biomarker Access
RECRUITING · NA
-
Mapping of Human Cognition
RECRUITING · NA
-
LITT Followed by Hypofractionated RT for Recurrent Gliomas
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia